These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15349561)

  • 41. Managing Cancer Relapse After Radical Prostatectomy: Adjuvant Versus Salvage Radiation Therapy.
    Rodriguez JF; Liauw SL; Eggener SE
    Urol Clin North Am; 2017 Nov; 44(4):597-609. PubMed ID: 29107276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjuvant and salvage radiotherapy after radical prostatectomy.
    Höcht S; Wiegel T; Schostak M; Hinkelbein W
    Onkologie; 2002 Jun; 25(3):201-6. PubMed ID: 12119453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [When is a nonsurgical approach possible for metastatic primary tumors and lymph node metastases of the urinary bladder and prostate?].
    Fietkau R
    Urologe A; 2017 May; 56(5):570-578. PubMed ID: 28424830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients.
    Mauermann J; Fradet V; Lacombe L; Dujardin T; Tiguert R; Tetu B; Fradet Y
    Eur Urol; 2013 Jul; 64(1):19-25. PubMed ID: 22901983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mortality Similar for Prostate Cancer Therapies.
    Cancer Discov; 2016 Dec; 6(12):OF7. PubMed ID: 27920141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.
    Song C; Kang HC; Kim JS; Eom KY; Kim IA; Chung JB; Hong SK; Byun SS; Lee SE
    Strahlenther Onkol; 2015 Oct; 191(10):801-9. PubMed ID: 26159555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Adjuvant medical treatment or radiotherapy following radical prostatectomy or curative radiotherapy].
    Guy L
    Bull Cancer; 2007 Jul; 94(7 Suppl):F15-20. PubMed ID: 17845989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural history of patients presenting biochemical recurrence after radical prostatectomy: some good news?
    Guillonneau BD; Fizazi K
    Eur Urol; 2011 Jun; 59(6):900-1. PubMed ID: 21419564
    [No Abstract]   [Full Text] [Related]  

  • 49. Therapeutic options for a rising PSA after radical prostatectomy.
    Carthon BC; Marcus DM; Herrel LA; Jani AB; Rossi PJ; Canter DJ
    Can J Urol; 2013 Jun; 20(3):6748-55. PubMed ID: 23783041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancing the efficacy of radical prostatectomy in locally advanced prostate cancer.
    Altwein JE
    Urol Int; 1998; 60 Suppl 2():2-10; discussion 35. PubMed ID: 9607552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aetiology and management of earlier vs later biochemical recurrence after retropubic radical prostatectomy.
    Llukani E; Lepor H
    BJU Int; 2017 Oct; 120(4):505-510. PubMed ID: 28220652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiation therapy for a rising PSA level after radical prostatectomy.
    Tiguert R; Forman JD; Hussain M; Wood DP
    Semin Urol Oncol; 1999 Aug; 17(3):141-7. PubMed ID: 10462317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiotherapy following radical prostatectomy.
    Patel P; Lee WR
    Expert Rev Anticancer Ther; 2012 Jul; 12(7):973-9. PubMed ID: 22845412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy.
    Eisenberg MS; Karnes RJ; Kaushik D; Rangel L; Bergstralh EJ; Boorjian SA
    J Urol; 2013 Nov; 190(5):1735-41. PubMed ID: 23727312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural history of biochemical recurrence after radical prostatectomy with adjuvant radiation therapy.
    Boorjian SA; Tollefson MK; Thompson RH; Rangel LJ; Bergstralh EJ; Karnes RJ
    J Urol; 2012 Nov; 188(5):1761-6. PubMed ID: 22998913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Salvage radiotherapy in rising PSA after radical prostatectomy].
    Carrie C; Pommier P
    Cancer Radiother; 2007 Nov; 11(6-7):370-2. PubMed ID: 17869564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
    Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
    J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Comparison Between Low-Dose-Rate Brachytherapy With or Without Androgen Deprivation, External Beam Radiation Therapy With or Without Androgen Deprivation, and Radical Prostatectomy With or Without Adjuvant or Salvage Radiation Therapy for High-Risk Prostate Cancer.
    Ciezki JP; Weller M; Reddy CA; Kittel J; Singh H; Tendulkar R; Stephans KL; Ulchaker J; Angermeier K; Stephenson A; Campbell S; Haber GP; Klein EA
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):962-975. PubMed ID: 28333019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiation therapy after radical prostatectomy: a review of the issues and options.
    Valicenti RK; Gomella LG; Perez CA
    Semin Radiat Oncol; 2003 Apr; 13(2):130-40. PubMed ID: 12728442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques.
    Duchesne GM; Haworth A; Bone E; Carter H; Ebert MA; Gagliardi F; Gibbs A; Hornby C; Martin A; Sidhom M; Wood M; Jackson M
    J Med Imaging Radiat Oncol; 2016 Feb; 60(1):129-37. PubMed ID: 26439588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.